- Home
- LPTH vs ARMP Comparison
LPTH vs ARMP Comparison
Compare LPTH & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- ARMP
- Stock Information
- Founded
- LPTH 1985
- ARMP N/A
- Country
- LPTH United States
- ARMP United States
- Employees
- LPTH N/A
- ARMP N/A
- Industry
- LPTH Semiconductors
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPTH Technology
- ARMP Health Care
- Exchange
- LPTH Nasdaq
- ARMP Nasdaq
- Market Cap
- LPTH 81.1M
- ARMP 52.1M
- IPO Year
- LPTH 1996
- ARMP N/A
- Fundamental
- Price
- LPTH $2.41
- ARMP $1.36
- Analyst Decision
- LPTH Strong Buy
- ARMP Strong Buy
- Analyst Count
- LPTH 3
- ARMP 1
- Target Price
- LPTH $4.67
- ARMP $7.00
- AVG Volume (30 Days)
- LPTH 101.0K
- ARMP 15.0K
- Earning Date
- LPTH 05-15-2025
- ARMP 05-20-2025
- Dividend Yield
- LPTH N/A
- ARMP N/A
- EPS Growth
- LPTH N/A
- ARMP N/A
- EPS
- LPTH N/A
- ARMP N/A
- Revenue
- LPTH $32,158,517.00
- ARMP $5,174,000.00
- Revenue This Year
- LPTH $16.90
- ARMP $8.43
- Revenue Next Year
- LPTH $52.77
- ARMP N/A
- P/E Ratio
- LPTH N/A
- ARMP N/A
- Revenue Growth
- LPTH N/A
- ARMP 14.24
- 52 Week Low
- LPTH $1.04
- ARMP $0.90
- 52 Week High
- LPTH $4.42
- ARMP $3.45
- Technical
- Relative Strength Index (RSI)
- LPTH 59.62
- ARMP 47.08
- Support Level
- LPTH $2.27
- ARMP $1.29
- Resistance Level
- LPTH $2.55
- ARMP $1.70
- Average True Range (ATR)
- LPTH 0.15
- ARMP 0.17
- MACD
- LPTH 0.03
- ARMP 0.02
- Stochastic Oscillator
- LPTH 78.46
- ARMP 34.62
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.